OTCQB:PMCB - OTCQX:BNPQY - OTCQX:IVPAF - OTCQB:LBUY - OTCQX:BLEVF - PINK:SMKC - 24/7 Market News

Venture Breakfast Bits, by 24/7 Market News

2018-10-01T09:59:55+00:00 Oct. 1, 2018 9:58AM EST|

Venture Market News for October 1, 2018

  • PharmaCyte Biotech Reports Completion of Crucial FDA-Required Study for Pancreatic Cancer Trial

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has successfully determined the modified site and chromosome location of the cytochrome P450-2B1 gene in the DNA of the genetically altered human cells known as 22P1G that will be encapsulated and used together with the cancer prodrug ifosfamide in PharmaCyte’s upcoming clinical trial. The cytochrome P450-2B1 gene is responsible for producing the enzyme that activates the ifosfamide into its cancer-killing form. The “integration site” information from this study was another requirement requested by the FDA. The site of integration was to be defined and included in PharmaCyte’s Investigational New Drug Application (IND) before the start of the clinical trial for the treatment of locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC).

Full press release

  • BNP Paribas Asset Management Launches Actively-Managed Emerging Markets Equity Fund

NEW YORK, Oct. 01, 2018 (GLOBE NEWSWIRE) -- BNP Paribas Asset Management (BNPP AM) is pleased to announce the launch of a new Emerging Markets Equity mutual fund. This fund joins our suite of recently launched mutual funds including: the Emerging Markets Total Return Fixed Income fund (launched Dec 2017) and the U.S. Small Cap Equity fund (launched Jan 2018).

Full press release

  • Ivanhoe Mines announces the Makoko Copper Discovery on its 100%-owned Western Foreland exploration licences near Kamoa-Kakula in the Democratic Republic of Congo

Vancouver, BC, Canada, October 1, 2018 OTC Disclosure & News Service—

This release includes additional documents.

Full press release

  • Leafbuyer Technologies, Inc. Posts 42% Year on Year Sales Gains

Leafbuyer Technologies, Inc. (LBUY) (“Leafbuyer”), a leading cannabis technology platform, announced that yearly sales rose 42% in the fiscal year ending June 30th, 2018. The increase reflects the cash sales booked in the year versus the previous year.

Full press release

  • Beleave Provides Update on B.C. Indoor Facilities

TORONTO, Oct 1, 2018 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it is has filed an application with Health Canada and, once approved, is ready to proceed with phase one in Chilliwack of the its recently-announced indoor cultivation cannabis project in British Columbia.

Full press release

  • Smoke Cartel Launches MindCBD.com and Enters Rapidly Growing CBD Market

SAVANNAH, GA, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Smoke Cartel, Inc. (Ticker: SMKC), a leading online retailer and wholesaler of glass water pipes, vaporizers, and other related accessories for the cannabis industry, today announced it has launched MindCBD.com to enter the rapidly growing cannabidiol (CBD) market.

Full press release

  • National Football Champion Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

Former NFL Player Derek Kennard Aims to Spread Awareness on Benefits of CBD

SAN DIEGO, Oct. 1, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former Dallas Cowboys offensive lineman and Super Bowl champion Derek Kennard has become a spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of cannabidiol (CBD) for athletes and active consumers.

Full press release

Connect with 24/7 Market News on social media

https://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com 

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements

CONTACT:

24/7 Market News

Editor@247marketnews.com

Send this to a friend

Hi, this may be interesting you: Kraig Biocraft Laboratories’ New R&D Facility Extends Its Competitive Advantages and Prepares for Large Scale Production! This is the link: https://www.247marketnews.com/kraig-biocraft-laboratories-new-rd-facility-extends-its-competitive-advantages-and-prepares-for-large-scale-production/